{"id":"NCT00754572","sponsor":"Hoffmann-La Roche","briefTitle":"A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis","officialTitle":"A Single-arm, Open-label Study of the Safety and Reduction of Signs and Symptoms During Treatment With Tocilizumab in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02","primaryCompletion":"2012-10","completion":"2012-10","firstPosted":"2008-09-18","resultsPosted":"2015-05-15","lastUpdate":"2015-05-15"},"enrollment":418,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"tocilizumab [RoActemra/Actemra]","otherNames":[]},{"type":"DRUG","name":"methotrexate","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"This single arm, open-label study will assess the safety and efficacy with regar d to reduction of signs and symptoms of treatment with tocilizumab in combinatio n with methotrexate, in patients with moderate to severe active rheumatoid arthr itis. Patients will receive tocilizumab 8mg/kg iv, every 4 weeks and methotrexat e 10-25mg weekly. The anticipated time on study treatment is 3-12 months, and th e target sample size is \\<500 individuals.","primaryOutcome":{"measure":"Percentage of Participants With American College of Rheumatology (ACR) 50 Response at Week 24","timeFrame":"Week 24","effectByArm":[{"arm":"Tocilizumab","deltaMin":73.23,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":69,"countries":["Argentina","Brazil","Chile","Colombia","Costa Rica","Ecuador","Mexico","Peru","Uruguay","Venezuela"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":30,"n":418},"commonTop":["Hypercholesterolemia","Hepatic enzyme increased","Headache","Urinary tract infection","Hypertriglyceridaemia"]}}